News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
335 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19557)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Business
Zymeworks Reports 2018 First Quarter Financial Results
Zymeworks Inc. reported financial results for the quarter ended March 31, 2018.
May 1, 2018
·
7 min read
Universal Health Services, Inc. To Present At May Healthcare Conferences
Universal Health Services, Inc. announced that Steve Filton, Executive Vice President and Chief Financial Officer will present at several conferences
May 1, 2018
·
1 min read
Business
Improving Patient Outcomes From Symptom Onset to Resolution - Laerdal Medical Introduces SimMan® Vascular
Laerdal Medical has partnered with Mentice to develop SimMan® Vascular to support the multidisciplinary team training and skills practice required.
May 1, 2018
·
2 min read
Job Trends
Alcon Introduces AIR OPTIX® COLORS Contact Lenses Gemstone Collection, Creating New Ways to Enhance and Play with Eye Color
Alcon is launching the new AIR OPTIX® COLORS Gemstone Collection of contact lenses.
May 1, 2018
·
9 min read
Business
Aurinia Pharmaceuticals to Release First Quarter 2018 Financial Results on May 10, 2018
Aurinia Pharmaceuticals Inc. announced that it will release its first quarter 2018 financial results on Thursday, May 10, 2018, after the market closes.
May 1, 2018
·
1 min read
Business
TherapeuticsMD to Host First Quarter Financial Results Conference Call and Webcast on May 3
TherapeuticsMD, Inc. announced that it will host a conference call and live audio webcast to discuss its first quarter financial and business results on Thursday, May 3.
May 1, 2018
·
4 min read
Business
Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2018 Financial Results on May 10, 2018
Eagle Pharmaceuticals, Inc. announced that the Company will release its 2018 first quarter financial results on Thursday, May 10, 2018, before the market opens.
May 1, 2018
·
1 min read
Biotech Beach
Masimo to Present at Deutsche Bank 43rd Annual Health Care Conference
Masimo announced that its management is scheduled to present at the Deutsche Bank 43rd Annual Health Care Conference at the Intercontinental Hotel in Boston on Tuesday, May 8, 2018 at 9:20 a.m. Eastern Time.
May 1, 2018
·
2 min read
FDA
Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma
Novartis announced the US Food and Drug Administration (FDA) has approved Kymriah® (tisagenlecleucel) suspension for intravenous infusion for its second indication.
May 1, 2018
·
17 min read
Deals
Encompass Health completes acquisition of Camellia Healthcare
Encompass Health Corp. announced it completed its previously announced acquisition of privately owned Camellia Healthcare and its affiliated entities on May 1, 2018.
May 1, 2018
·
5 min read
Previous
31 of 34
Next